Month: April 2021

Conference CallAdvisory EDMONTON, Alberta, April 14, 2021 (GLOBE NEWSWIRE) — TSX,NYSE: STN Stantec will release its first quarter 2021 financial results after markets close on Wednesday, May 5, 2021. On Thursday, May 6, 2021, at 7:00 AM Mountain Time (9:00 AM Eastern Time), Gord Johnston, President and Chief Executive Officer, and Theresa Jang, Executive Vice President and Chief Financial Officer, will hold a conference call to discuss the Company’s performance. The webcast and slide presentation can be accessed at the following link:https://edge.media-server.com/mmc/p/umksu6hp The conference call and slideshow presentation will be broadcast live and archived in their entirety in the Investors section of stantec.com. Participants wishing to listen to the call via telephone may dial in toll-free at 1-800-367-2403 (Canada and United...

DAYTONA BEACH, Fla., April 14, 2021 (GLOBE NEWSWIRE) — J. Scott Penny, Chief Acquisitions Officer of Brown & Brown, Inc. (NYSE:BRO), and Steven V. Guarino, Michael S. Silver, and Shari M. Silver, the owners of Leon Silver Associates, LLC (Leon Silver), today announced that a Bridge Specialty Group company and subsidiary of Brown & Brown, Inc. has acquired substantially all of the assets of Leon Silver. Based in Metuchen, New Jersey, Leon Silver is a wholesale broker offering commercial and personal lines property and casualty insurance products through its network of retail agents in New York, New Jersey, Pennsylvania, Florida, Connecticut, and Delaware. The firm was founded by Michael and Shari Silver’s father, Leon G. Silver, and has roots dating back to 1971. Following the transaction, the Leon Silver operations will...

VAN BUREN TOWNSHIP, Mich., April 14, 2021 (GLOBE NEWSWIRE) — Visteon Corporation (Nasdaq: VC), a global automotive electronics technology enterprise dedicated to creating more enjoyable, connected and safe driving experiences, will release its first-quarter 2021 financial results prior to 7 a.m. ET on Thursday, April 29. The company will host a conference call for the investment community at 9 a.m. ET to discuss the results and related matters. The conference call also is available to the general public via a live audio webcast. The dial-in numbers to participate in the call are: U.S./Canada: 866-411-5196  Outside U.S./Canada: 970-297-2404Conference ID: 1997539 (Call approximately 10 minutes before the start of the conference.) The conference call and live audio webcast, related presentation materials, news release and other supplemental...

Efter salget af selskabets aktiepost i Rias A/S består selskabets aktiver i al væsentlighed af likvider. Bestyrelsen har på den baggrund besluttet at foretage en ekstraordinær udlodning på DKK 4,00 pr. aktie, svarende til en samlet udlodning på DKK 15m. Nærmere om udlodningenUdbetaling sker via VP Securities A/S på baggrund af de beholdninger, der er registreret tirsdag d. 20. april 2021 ved dagens afslutning. Aktier i SmallCap Danmark A/S, der handles med normal valør (T+2) og handles til og med fredag d. 16 april 2021, vil således være handlet inklusive retten til den ekstraordinære udlodning. Aktier handlet fra og med mandag d. 19 april 2021 og handlet med normal valør (T+2) vil være handlet eksklusive retten til det ekstraordinære udbytte. Udbyttet forventes at være til disposition på aktionæ­rernes konti onsdag d. 21. april 2021. Udlodningen...

Lille, le 14 avril 2021 Communiqué Avis de mise à disposition du rapport financier 2020 du Crédit Agricole Nord de France La Caisse régionale du Crédit Agricole Nord de France annonce avoir mis à disposition du public et déposé auprès de l’Autorité des Marchés Financiers son rapport financier pour les comptes arrêtés au 31 décembre 2020. Le rapport peut être consulté sur le site de présentation du Crédit Agricole Nord de France à l’adresse http://communication.ca-norddefrance.fr/, rubrique publications. Contact : Catherine FilonczukCrédit Agricole Nord de France Tél. : 03.20.63.72.68catherine.filonczuk@ca-norddefrance.fr Pièce jointeavis de mise a disposition-rapport financier 2020

NEW YORK, NY, April 14, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant, Cherry Lime Rickey, Golden Raspberry), additional product offerings, as well as an ongoing Pharmaceutical Development initiative, today announced that it has received substantial Pre-Orders for its new, 25mg CBD & CBG infused Tauri-Gum™ versions.  The enhanced 25mg CBD & CBG infusion concentrations apply to five distinct Tauri-Gum™ SKUs: Mint (CBD), Blood Orange (CBD), Pomegranate (CBD), Peach-Lemon (CBG), and Black Currant (CBG). CBD = CANNABIDIOL CBG = CANNABIGEROL The...

ST. LOUIS , April 14, 2021 (GLOBE NEWSWIRE) — Amdocs (NASDAQ: DOX), a leading provider of software and services to communications and media companies, today announced that it has joined the Open Networking Foundation (ONF) as a new member. ONF is a non-profit operator-led consortium driving transformation of network infrastructure and carrier business models utilizing network disaggregation, white box economics, open source software and software defined standards. By joining ONF, Amdocs continues to build on its commitment to drive service innovation and operations agility through advanced service and network automation solutions based on open interfaces, industry standards, data-driven Artificial Intelligence (AI), Machine Learning (ML) and cloud-native technology. Amdocs will engage with the ONF SD-RAN project, which is focused...

TEL AVIV, Israel, April 14, 2021 (GLOBE NEWSWIRE) — Vascular Biogenics Ltd. (“VBL Therapeutics” or the “Company”) (NASDAQ: VBLT), today announced the closing of its underwritten public offering of 6,901,790 ordinary shares, and, to certain investors in lieu thereof, pre-funded warrants to purchase 8,050,000 ordinary shares in an underwritten public offering, at a price to the public of $1.90 per ordinary share and $1.89 per pre-funded warrant. The pre-funded warrants allow investors that have restrictions on their ability to own Company stock above a designated ownership threshold (such as 4.99% or 19.99%) to invest additional capital. In practice, the pre-funded warrants are the equivalent to ordinary shares without voting rights. All of the securities in the offering were sold by VBL Therapeutics. The gross proceeds to the Company...